Quick Answer
ESCALON MEDICAL CORP reported Research And Development Expense of $753.1 thousand for the year ending 2025.
- ESCALON MEDICAL CORP showed an increase of +9.4% in Research And Development Expense from 2024 to 2025.
- This data is from ESCALON MEDICAL CORP's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), ESCALON MEDICAL CORP's Research And Development Expense has declined by 53.0%.
- Historical annual values: Fiscal year 2025: $753.1 thousand | Fiscal year 2024: $688.2 thousand | Fiscal year 2023: $818.8 thousand | Fiscal year 2022: $991.0 thousand | Fiscal year 2021: $890.5 thousand | Fiscal year 2020: $1.12 million | Fiscal year 2019: $739.8 thousand | Fiscal year 2018: $500.3 thousand | Fiscal year 2017: $1.05 million | Fiscal year 2016: $1.45 million | Fiscal year 2015: $1.30 million | Fiscal year 2014: $1.31 million | Fiscal year 2013: $1.11 million | Fiscal year 2012: $1.00 million | Fiscal year 2011: $1.60 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: